Infectivity of HBV DNA positive donations identified in look-back studies in Hyogo-Prefecture, Japan

Transfusion Medicine

Volumn 21, Issue 2, 2011, Pages 107-115

  Bouike, Y ^a,b   Imoto, S ^a,c   Mabuchi, O ^a   Kokubunji, A ^d   Kai, S ^d   Okada, M ^d   Taniguchi, R ^a   Momose, S ^e   Uchida, S ^f   Nishio, H ^b  

^a Japanese Red Cross Hyogo Blood Centre   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KOBE TOKIWA UNIVERSITY   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

^e SUWA RED CROSS HOSPITAL   (Japan)

^f Japanese Red Central Blood Center   (Japan)

Author keywords

HBV; ID NAT; Look back study; MP NAT; TTHBI

Indexed keywords

VIRUS DNA;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; DNA DETERMINATION; DONOR SELECTION; FOLLOW UP; HEPATITIS B; HUMAN; INDIVIDUAL DONATION NUCLEIC ACID AMPLIFICATION TEST; JAPAN; MINI POOL NUCLEIC ACID AMPLIFICATION TEST; NUCLEIC ACID AMPLIFICATION; OUTCOME ASSESSMENT; RECIPIENT; RED CROSS; SEROLOGY; VIRUS TRANSMISSION;

BIOLOGICAL MARKERS; BLOOD DONORS; BLOOD SAFETY; BLOOD TRANSFUSION; DNA, VIRAL; FALSE NEGATIVE REACTIONS; FATAL OUTCOME; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; JAPAN; MALE; MASS SCREENING; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RETROSPECTIVE STUDIES; VIREMIA; VIRULENCE;

EID: 79951625179     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2010.01057.x     Document Type: Article

References (18)

1. Comanor, L. & Holland, P. (2006) Hepatitis B virus blood screening: unfinished agendas. Vox Sanguinis, 91, 1-12.
2. Hollinger, F.B. & Dodd, R.Y. (2009) Hepatitis B virus traceback and lookback: factors to consider. Transfusion, 49, 176-184.
3. Inaba, S., Ito, A., Miyata, Y. et al. (2006) Individual nucleic amplification technology does not prevent all hepatitis B virus transmission by blood transfusion. Transfusion, 46, 2028-2029.
4. Japanese Red Cross NAT Screening Research Group. (2000) Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors. Japanese Journal of Infectious Diseases, 53, 116-123.
5. Mine, H., Emura, H., Miyamoto, M. et al. (2003) High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. Journal of Virological Methods, 112, 145-151.
6. Minegishi, K., Yoshikawa, A., Kishimoto, S., Yugi, H., Yokoya, N., Sakurada, M., Kiyokawa, H., Nishioka, K. & the Japanese Red Cross NAT Screening Research Group. (2003) Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening. Vox Sanguinis, 84, 287-291.
7. Ministry of Health, Labour and Welfare of Japan. (2009) Report of the Blood Program Steering Committee, Blood Program division Pharmaceutical Affairs Food Sanitation Council. URL (Accessed 28/7/09).
8. Okamoto, H., Yotsumoto, S., Akahane, Y. et al. (1990) Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. Journal of Virology, 64, 1298-1303.
9. Satake, M. (2007) Japanese repositories. Transfusion, 47, 1105.
10. Satake, M. & Tadokoro, K. (2008) Transfusion-transmitted hepatitis verified from haemovigilance and look-back study. ISBT Science Series, 3, 107-110.
11. Satake, M., Taira, R., Yugi, H., Hino, S., Kanemitsu, K., Ikeda, H. & Tadokoro, K. (2007) Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion, 47, 1197-1205.
12. Schreiber, G.B., Busch, M.P., Kleinman, S.H. & Korelitz, J.J. (1996) The risk of transfusion-transmitted viral infections. The New England Journal of Medicine, 334, 1685-1690.
13. Tadokoro, K. (2007) The new Japanese blood law: its impact on blood safety and usage. Developmental Biology, 127, 161-168.
14. Wendel, S., Levi, J.E., Biagini, S., Candotti, D. & Allain, J.P. (2008) A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period. Transfusion, 48, 1602-1608.
15. Yoshikawa, A., Gotanda, Y., Itabashi, M., Minegishi, K., Kanemitsu, K., Nishioka, K. & the Japanese Red Cross NAT Screening Research Group. (2005) Hepatitis B NAT virus-positive blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA. Vox Sanguinis, 88, 77-86.
16. Yugi, H., Hino, S., Satake, M. & Tadokoro, K. (2005) Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology in Japan. Vox Sanguinis, 89, 265.
17. Yugi, H., Mizui, M., Tanaka, J. & Yoshizawa, H. (2006) Hepatitis B virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing - Japanese experience. Journal of Clinical Virology, 36, S56-S64.
18. Yuki, N., Nagaoka, T., Yamashiro, M. et al. (2003) Long-term histologic and virologic outcomes of acute self-limited hepatitis B. Hepatology, 37, 1172-1179.